indazoles has been researched along with Myositis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hiramatsu, H; Hiraoka, S; Kato, I; Kosaka, T; Mizowaki, T; Sakamoto, A; Takita, J; Umeda, K; Uto, M | 1 |
Apicella, C; Guglielmotti, A; Mahalingam, S; Mangano, G; Rolph, MS; Rulli, NE; Suhrbier, A; Zaid, A | 1 |
Anantapreecha, S; Guglielmotti, A; Mahalingam, S; Rolph, MS; Rulli, NE; Srikiatkhachorn, A | 1 |
3 other study(ies) available for indazoles and Myositis
Article | Year |
---|---|
Radiation recall myositis caused by pazopanib in a patient with refractory osteosarcoma.
Topics: Humans; Indazoles; Myositis; Osteosarcoma; Pyrimidines; Sulfonamides | 2021 |
Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins.
Topics: Alphavirus; Alphavirus Infections; Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Line; Disease Models, Animal; Down-Regulation; Humans; Indazoles; Macrophages; Mice; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; Muscle, Skeletal; Myositis; Propionates; RNA, Messenger | 2009 |
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Topics: Alphavirus Infections; Animals; Arthritis, Infectious; Chemokine CCL2; Chikungunya Fever; Chikungunya virus; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred C57BL; Models, Animal; Myositis; Propionates; Tumor Necrosis Factor-alpha; Viral Load | 2011 |